Michelle Perez
Neuroscience · Miami, FLNPI 1629366323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2023 is the largest year on record at $1,587, more than ten times the $81 reported in 2021.
Across 86 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$351
- UCB, Inc.$304
- Corium, LLC$219
- Jazz Pharmaceuticals Inc.$217
- Sumitomo Pharma America, Inc.$196
- Ironshore Pharmaceuticals Inc.$152
- plus $733 from 15 others
What the payments were for
- Food & beverage$2,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 20 | $351 |
| UCB, Inc. | 7 | $304 |
| Corium, LLC | 8 | $219 |
| Jazz Pharmaceuticals Inc. | 4 | $217 |
| Sumitomo Pharma America, Inc. | 8 | $196 |
| Ironshore Pharmaceuticals Inc. | 9 | $152 |
| Immedica Pharma US, Inc. | 1 | $122 |
| SK Life Science, Inc. | 5 | $102 |
| Aquestive Therapeutics, Inc. | 4 | $90 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 |
| Biogen | 3 | $64 |
| Biocodex, Inc. | 1 | $59 |
| Livanova USA, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $38 |
| Aprecia Pharmaceuticals, LLC | 2 | $30 |
| AbbVie | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| NS Pharma, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuroscience providers in Floridato place this figure against a meaningful peer group, so we don't.
Other neuroscience in Miami
- Amy ToenjesJacksonville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.